The stock's fall snapped a two-day winning streak.

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s ...

Magrolimab triple therapy falls short of expectations in a study of previously untreated acute myeloid leukemia.

Despite decades of medical progress, HIV continues to devastate Black communities. The statistics are sobering. The disparities, undeniable.

Over 60% of patients who received ervogastat plus clesacostat for 48 weeks achieved MASH resolution without fibrosis ...

Ten grants funded through the first round of the Guiding Local Opportunities for Wellbeing (GLOWS) Indigenous Health Grant program spanning ...

Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.

A Peninsula biotech company is making a dramatic pivot, leaving behind its focus on inflammatory diseases for a surprising ...

Total revenue for the three months ended June 30, 2025 increased by $1.5 million as compared to the three months ended June 30, 2024, primarily as a result of increases in Incyte revenue of $1.5 ...

Detailed price information for Pheton Holdings Ltd Cl A (PTHL-Q) from The Globe and Mail including charting and trades.

The Dow opened 73.68 points higher on Tuesday, extending solid gains recorded in the previous session as US stocks rebounded ...

DelveInsight's TYK2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...